A breakthrough study highlights Xenon gas as a potential game-changer in treating Alzheimer’s disease, demonstrating its ...
The Davos Alzheimer’s Collaborative (DAC), a pioneering worldwide initiative seeking to cure Alzheimer’s disease and improve ...
Study reveals surprising connection between common childhood virus CMV and Alzheimer's disease, offering new insights into ...
Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...
7d
Anavex Life Sciences' Blarcamesine trial raises concerns over approval. Learn why AVXL stock is undervalued, reflecting the ...
Former study was recently accepted in a peer-reviewed medical journal with focus on Alzheimer’s disease titled, “Blarcamesine for the treatment ... based on current information and ...
It should come as no surprise that Alzheimer’s has touched ... living with the disease. By 2060, that number is projected to grow to nearly 14 million — doubling the current total ...
On track to report data from Phase 1 clinical trial evaluating VG-3927 for the treatment of Alzheimer’s disease in 1Q 2025 ... are based on Vigil’s current expectations and are subject ...
With these key hires, Alpha Cognition is poised to advance its mission of improving the lives of patients and families ...
WATERTOWN, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology ...
An international commission made the case for focusing on body fat quantity and the illnesses people experience.
New dementia patients can expect to live fewer than five years after diagnosis, major analysis finds
Older adults with healthier lifestyles also tend to live longer, even if they have dementia. “Current ... benefits of new treatments that aim to slow the progression of the disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback